A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Using exome data to identify malignant hyperthermia susceptibility mutations.
Stephen G Gonsalves, David Ng, Jennifer J Johnston, Jamie K Teer, Peter D Stenson, David N Cooper, James C Mullikin, Leslie G Biesecker. Anesthesiology 2013
54
50

Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
Jennifer J Johnston, Wendy S Rubinstein, Flavia M Facio, David Ng, Larry N Singh, Jamie K Teer, James C Mullikin, Leslie G Biesecker. Am J Hum Genet 2012
160
50

Performance of exome sequencing for pharmacogenomics.
Eric R Londin, Peter Clark, Marialuisa Sponziello, Larry J Kricka, Paolo Fortina, Jason Y Park. Per Med 2014
14
50

Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.
C A Fernandez, C Smith, W Yang, R Lorier, K R Crews, N Kornegay, J K Hicks, C F Stewart, J D Kawedia, L B Ramsey,[...]. Clin Pharmacol Ther 2012
36
50

Actionable, pathogenic incidental findings in 1,000 participants' exomes.
Michael O Dorschner, Laura M Amendola, Emily H Turner, Peggy D Robertson, Brian H Shirts, Carlos J Gallego, Robin L Bennett, Kelly L Jones, Mari J Tokita, James T Bennett,[...]. Am J Hum Genet 2013
268
50

Clinical pharmacogenetics implementation: approaches, successes, and challenges.
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
125
50


Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
M V Relling, E E Gardner, W J Sandborn, K Schmiegelow, C-H Pui, S W Yee, C M Stein, M Carrillo, W E Evans, J K Hicks,[...]. Clin Pharmacol Ther 2013
227
50

Achieving high-sensitivity for clinical applications using augmented exome sequencing.
Anil Patwardhan, Jason Harris, Nan Leng, Gabor Bartha, Deanna M Church, Shujun Luo, Christian Haudenschild, Mark Pratt, Justin Zook, Marc Salit,[...]. Genome Med 2015
35
50

Diagnostic clinical genome and exome sequencing.
Leslie G Biesecker, Robert C Green. N Engl J Med 2014
346
50

Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.
John Logan Black, Denise L Walker, Dennis J O'Kane, Maria Harmandayan. Drug Metab Dispos 2012
37
50

Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.
K E Caudle, C F Thorn, T E Klein, J J Swen, H L McLeod, R B Diasio, M Schwab. Clin Pharmacol Ther 2013
227
50

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden,[...]. Clin Pharmacol Ther 2014
226
50

Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform.
Tristan M Sissung, Bevin C English, David Venzon, William D Figg, John F Deeken. Pharmacogenomics 2010
46
50

Interpreting secondary cardiac disease variants in an exome cohort.
David Ng, Jennifer J Johnston, Jamie K Teer, Larry N Singh, Lindsey C Peller, Jamila S Wynter, Katie L Lewis, David N Cooper, Peter D Stenson, James C Mullikin,[...]. Circ Cardiovasc Genet 2013
56
50

Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transport.
Thomas M Daly, Carmen M Dumaual, Xin Miao, Mark W Farmen, Reuben K Njau, Dong-Jing Fu, Nancy L Bauer, Sandra Close, Nancy Watanabe, Carsten Bruckner,[...]. Clin Chem 2007
41
50

The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine.
Leslie G Biesecker, James C Mullikin, Flavia M Facio, Clesson Turner, Praveen F Cherukuri, Robert W Blakesley, Gerard G Bouffard, Peter S Chines, Pedro Cruz, Nancy F Hansen,[...]. Genome Res 2009
203
50

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014
382
50

Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX(®) ADME PGx Panel for Pharmacogenomic Profiling.
Eng Wee Chua, Simone L Cree, Kim N T Ton, Klaus Lehnert, Phillip Shepherd, Nuala Helsby, Martin A Kennedy. Front Pharmacol 2016
74
50

The limits of genome-wide methods for pharmacogenomic testing.
Eric R Gamazon, Andrew D Skol, Minoli A Perera. Pharmacogenet Genomics 2012
23
50

Atlas-CNV: a validated approach to call single-exon CNVs in the eMERGESeq gene panel.
Theodore Chiang, Xiuping Liu, Tsung-Jung Wu, Jianhong Hu, Fritz J Sedlazeck, Simon White, Daniel Schaid, Mariza de Andrade, Gail P Jarvik, David Crosslin,[...]. Genet Med 2019
10
50


Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.
Robbert D A Weren, Arjen R Mensenkamp, Michiel Simons, Astrid Eijkelenboom, Aisha S Sie, Hicham Ouchene, Monique van Asseldonk, Encarna B Gomez-Garcia, Marinus J Blok, Joanne A de Hullu,[...]. Hum Mutat 2017
41
50

The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.
Ute I Schwarz, Markus Gulilat, Richard B Kim. Cold Spring Harb Perspect Med 2019
21
50




Genetic variation in the human cytochrome P450 supergene family.
Kohei Fujikura, Magnus Ingelman-Sundberg, Volker M Lauschke. Pharmacogenet Genomics 2015
86
50

Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.
Yao Yang, Mariana R Botton, Erick R Scott, Stuart A Scott. Pharmacogenomics 2017
43
50

Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6.
Wanqiong Qiao, Yao Yang, Robert Sebra, Geetu Mendiratta, Andrea Gaedigk, Robert J Desnick, Stuart A Scott. Hum Mutat 2016
51
50

Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients.
Margot A Cousin, Eric T Matey, Patrick R Blackburn, Nicole J Boczek, Tammy M McAllister, Teresa M Kruisselbrink, Dusica Babovic-Vuksanovic, Konstantinos N Lazaridis, Eric W Klee. Mol Genet Genomic Med 2017
12
50

Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.
Oscar Suzuki, Olivia M Dong, Rachel M Howard, Tim Wiltshire. Pharmacogenomics 2019
5
50

PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation.
Adam S Gordon, Robert S Fulton, Xiang Qin, Elaine R Mardis, Deborah A Nickerson, Steve Scherer. Pharmacogenet Genomics 2016
63
50

Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes.
Qingbo Wang, Emma Pierce-Hoffman, Beryl B Cummings, Jessica Alföldi, Laurent C Francioli, Laura D Gauthier, Andrew J Hill, Anne H O'Donnell-Luria, Konrad J Karczewski, Daniel G MacArthur. Nat Commun 2020
35
50

Prospective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE Network.
David R Crosslin, Peggy D Robertson, David S Carrell, Adam S Gordon, David S Hanna, Amber Burt, Stephanie M Fullerton, Aaron Scrol, James Ralston, Kathleen Leppig,[...]. Genome Med 2015
10
50

Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset.
Adam S Gordon, Holly K Tabor, Andrew D Johnson, Beverly M Snively, Themistocles L Assimes, Paul L Auer, John P A Ioannidis, Ulrike Peters, Jennifer G Robinson, Lara E Sucheston,[...]. Hum Mol Genet 2014
62
50

Comparison Between Clopidogrel and Prasugrel Associated With CYP2C19 Genotypes in Patients Receiving Percutaneous Coronary Intervention in a Japanese Population.
Yuichi Sawayama, Takashi Yamamoto, Yukinori Tomita, Kohei Asada, Noriaki Yagi, Megumi Fukuyama, Akashi Miyamoto, Hiroshi Sakai, Tomoya Ozawa, Tetsuichiro Isono,[...]. Circ J 2020
5
50

Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children.
Supharat Suvichapanich, Jiraphun Jittikoon, Nuanjun Wichukchinda, Wasu Kamchaisatian, Anannit Visudtibhan, Suwat Benjapopitak, Somjai Nakornchai, Wiparat Manuyakorn, Surakameth Mahasirimongkol. J Hum Genet 2015
21
50

Navigating highly homologous genes in a molecular diagnostic setting: a resource for clinical next-generation sequencing.
Diana Mandelker, Ryan J Schmidt, Arunkanth Ankala, Kristin McDonald Gibson, Mark Bowser, Himanshu Sharma, Elizabeth Duffy, Madhuri Hegde, Avni Santani, Matthew Lebo,[...]. Genet Med 2016
76
50

Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications.
Yusmiati Liau, Simran Maggo, Allison L Miller, John F Pearson, Martin A Kennedy, Simone L Cree. Pharmacogenomics 2019
16
50

GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes.
Tomoko Yoshihama, Koya Fukunaga, Akira Hirasawa, Hiroyuki Nomura, Tomoko Akahane, Fumio Kataoka, Wataru Yamagami, Daisuke Aoki, Taisei Mushiroda. Oncotarget 2018
13
50

Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care.
J Kevin Hicks, Amy Shealy, Allison Schreiber, Marissa Coleridge, Ryan Noss, Marvin Natowicz, Rocio Moran, Timothy Moss, Angelika Erwin, Charis Eng. Clin Transl Sci 2018
7
50

Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
S M Han, J Park, J H Lee, S S Lee, H Kim, H Han, Y Kim, S Yi, J-Y Cho, I-J Jang,[...]. Clin Pharmacol Ther 2017
31
50

Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.
Henk P J Buermans, Rolf H A M Vossen, Seyed Yahya Anvar, William G Allard, Henk-Jan Guchelaar, Stefan J White, Johan T den Dunnen, Jesse J Swen, Tahar van der Straaten. Hum Mutat 2017
30
50

Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics.
Maaike van der Lee, William G Allard, Sander Bollen, Gijs W E Santen, Claudia A L Ruivenkamp, Mariëtte J V Hoffer, Marjolein Kriek, Henk-Jan Guchelaar, Seyed Y Anvar, Jesse J Swen. Clin Pharmacol Ther 2020
7
50

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
Andrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, J Steven Leeder, Michelle Whirl-Carrillo, Teri E Klein. Clin Pharmacol Ther 2018
157
50

Targeted next generation sequencing as a tool for precision medicine.
Markus Gulilat, Tyler Lamb, Wendy A Teft, Jian Wang, Jacqueline S Dron, John F Robinson, Rommel G Tirona, Robert A Hegele, Richard B Kim, Ute I Schwarz. BMC Med Genomics 2019
21
50

CoNVaDING: Single Exon Variation Detection in Targeted NGS Data.
Lennart F Johansson, Freerk van Dijk, Eddy N de Boer, Krista K van Dijk-Bos, Jan D H Jongbloed, Annemieke H van der Hout, Helga Westers, Richard J Sinke, Morris A Swertz, Rolf H Sijmons,[...]. Hum Mutat 2016
49
50

Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.
Yukihide Momozawa, Yusuke Iwasaki, Michael T Parsons, Yoichiro Kamatani, Atsushi Takahashi, Chieko Tamura, Toyomasa Katagiri, Teruhiko Yoshida, Seigo Nakamura, Kokichi Sugano,[...]. Nat Commun 2018
59
50

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
W S Bush, D R Crosslin, A Owusu-Obeng, J Wallace, B Almoguera, M A Basford, S J Bielinski, D S Carrell, J J Connolly, D Crawford,[...]. Clin Pharmacol Ther 2016
96
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.